葡萄糖胺文獻薈萃報告 — 2026 年 2 月

摘要

本月共收錄 葡萄糖胺 相關文獻 620 篇,其中 Level 1 證據(Meta-Analysis/Systematic Review)34 篇,RCT 23 篇。

證據等級分布

證據等級 文獻數 佔比
Level 1 (Meta-Analysis/Systematic Review) 34 5.5%
Level 2 (RCT) 23 3.7%
Level 3 (Clinical Trial) 2 0.3%
Level 4 (Observational) 2 0.3%
Level 5 (Review/Case Report/Other) 559 90.2%

功效分類統計

功效分類 中文 文獻數 佔比
musculoskeletal 肌肉骨骼 492 79.4%
immune 免疫調節 219 35.3%
skin 皮膚 133 21.5%
other 其他 63 10.2%
anti_aging 抗衰老 62 10.0%
metabolic 代謝 61 9.8%
cardiovascular 心血管 54 8.7%
digestive 消化 29 4.7%
cognitive 認知功能 15 2.4%
energy 活力 10 1.6%

成分搭配統計

成分 文獻數
chondroitin 406
glucosamine 249
EPA 171
collagen 115
hyaluronic acid 88
iron 67
stem cell 62
NAC 32
fiber 16
calcium 15

成分組合分析

以下列出最常被共同研究的成分組合:

成分組合 共同出現文獻數
EPA + chondroitin 139
chondroitin + collagen 92
chondroitin + glucosamine 91
chondroitin + hyaluronic acid 74
chondroitin + stem cell 55
chondroitin + iron 54
EPA + collagen 40
collagen + glucosamine 39
EPA + glucosamine 39
EPA + stem cell 38

成分功效分析

以下列出主要成分在各功效領域的研究文獻數:

成分 總文獻 肌肉骨骼 免疫調節 皮膚 抗衰老 其他 代謝
chondroitin 406 310 139 103 38 47 35
glucosamine 249 233 106 46 28 4 30
EPA 171 124 57 45 20 24 11
collagen 115 90 33 115 17 - 8
hyaluronic acid 88 68 30 25 6 9 4
iron 67 50 28 15 11 7 5
stem cell 62 41 15 24 3 11 3
NAC 32 24 13 8 4 4 4

研究類型分布

研究類型 文獻數 佔比
Meta-Analysis 19 3.1%
Systematic Review 15 2.4%
RCT 23 3.7%
Clinical Trial 2 0.3%
Observational 2 0.3%
Review 69 11.1%
Case Report 9 1.5%
Other 481 77.6%

近期重要文獻

Level 1 證據(Meta-Analysis / Systematic Review)

  1. The efficacy and safety of hydrotherapy in patients with knee osteoarthritis: A protocol for systematic review and meta-analysis. — Medicine, 2023-02-22
    • 功效分類:immune, musculoskeletal, skin
  2. The Safety and Efficacy of Glucosamine and/or Chondroitin in Humans: A Systematic Review. — Nutrients, 2025-06-24
    • 功效分類:anti_aging, musculoskeletal
  3. Effects of adding glucosamine or glucosamine combined with chondroitin to exercise on pain and physical function in adults with knee osteoarthritis: a systematic review and meta-analysis. — European journal of translational myology, 2023-11-23
    • 功效分類:musculoskeletal
  4. [SYSADOA place in degenerative-dystrophic joints diseases treatment of neurological practice from the standpoint of evidence-based medicine]. — Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2022-01-01
    • 功效分類:anti_aging, cognitive, musculoskeletal
  5. Efficacy and safety of the combination of glucosamine and chondroitin for knee osteoarthritis: a systematic review and meta-analysis. — Archives of orthopaedic and trauma surgery, 2023-01-01
    • 功效分類:musculoskeletal

Level 2 證據(RCT)

  1. Randomized, double-blind, four-arm pilot study on the effects of chicken essence and type II collagen hydrolysate on joint, bone, and muscle functions. — Nutrition journal, 2023-03-15
    • 功效分類:musculoskeletal, skin
  2. Clinical risk factors associated with radiographic osteoarthritis progression among people with knee pain: a longitudinal study. — Arthritis research & therapy, 2021-06-04
    • 功效分類:cardiovascular, immune, metabolic, musculoskeletal
  3. Does glucosamine, chondroitin sulfate, and methylsulfonylmethane supplementation improve the outcome of temporomandibular joint osteoarthritis management with arthrocentesis plus intraarticular hyaluronic acid injection. A randomized clinical trial. — Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2021-08-01
    • 功效分類:musculoskeletal
  4. Pharmacokinetic Comparison of Chitosan-Derived and Biofermentation-Derived Glucosamine in Nutritional Supplement for Bone Health. — Nutrients, 2022-08-05
    • 功效分類:musculoskeletal
  5. Cost-Effectiveness Analysis of Pharmaceutical-Grade Chondroitin Sulfate for Knee Osteoarthritis Based on Individual Patient Data from a Randomized Clinical Trial. — Advances in therapy, 2025-01-01
    • 功效分類:musculoskeletal

免責聲明

本網站內容由 AI 自動生成,基於各國官方公開資料庫的產品登記資訊。 報告內容僅供參考,不構成醫療建議、投資建議或商業建議。 如有健康問題,請諮詢專業醫療人員。

產品統計以資料庫登記為準,不代表實際市場銷售狀況。 各國監管制度不同,跨國比較應考慮法規差異。


Copyright © 2026 保健食品產品情報系統